- Home
- AUDC vs AQST Comparison
AUDC vs AQST Comparison
Compare AUDC & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUDC
- AQST
- Stock Information
- Founded
- AUDC 1992
- AQST 2004
- Country
- AUDC Israel
- AQST United States
- Employees
- AUDC N/A
- AQST N/A
- Industry
- AUDC Telecommunications Equipment
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- AUDC Utilities
- AQST Health Care
- Exchange
- AUDC Nasdaq
- AQST Nasdaq
- Market Cap
- AUDC 299.7M
- AQST 274.4M
- IPO Year
- AUDC 1999
- AQST 2018
- Fundamental
- Price
- AUDC $9.42
- AQST $2.94
- Analyst Decision
- AUDC Buy
- AQST Strong Buy
- Analyst Count
- AUDC 2
- AQST 7
- Target Price
- AUDC $11.25
- AQST $10.57
- AVG Volume (30 Days)
- AUDC 72.0K
- AQST 1.4M
- Earning Date
- AUDC 05-06-2025
- AQST 03-05-2025
- Dividend Yield
- AUDC 1.91%
- AQST N/A
- EPS Growth
- AUDC 78.82
- AQST N/A
- EPS
- AUDC 0.50
- AQST N/A
- Revenue
- AUDC $242,176,000.00
- AQST $57,561,000.00
- Revenue This Year
- AUDC $5.11
- AQST N/A
- Revenue Next Year
- AUDC $3.79
- AQST $39.51
- P/E Ratio
- AUDC $19.10
- AQST N/A
- Revenue Growth
- AUDC N/A
- AQST 13.79
- 52 Week Low
- AUDC $7.70
- AQST $2.24
- 52 Week High
- AUDC $13.11
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- AUDC 27.46
- AQST 47.23
- Support Level
- AUDC $9.85
- AQST $3.05
- Resistance Level
- AUDC $10.13
- AQST $3.24
- Average True Range (ATR)
- AUDC 0.27
- AQST 0.20
- MACD
- AUDC -0.06
- AQST 0.02
- Stochastic Oscillator
- AUDC 12.41
- AQST 36.18
About AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells advanced and converged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.